Related Experiment Video

Updated: May 23, 2026

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

The potentials of selected therapeutic targets for inflammation: a snapshot

Sneha Nayadu1, Ginpreet Kaur, Girish Gudi

  • 1SPP School of Pharmacy & Technology Management, NMIMS, Vile Parle West, Mumbai, India.

Recent Patents on Inflammation & Allergy Drug Discovery
|March 22, 2012
PubMed

Insights

Inflammation involves complex cellular responses to injury, producing mediators that can be dysregulated in disease. This review explores novel therapeutic targets and strategies for modulating these inflammatory pathways.

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • Inflammation is a critical host defense mechanism against infection and injury.
  • Inflammatory cells produce diverse bioactive mediators like prostanoids, cytokines, and chemokines.
  • Dysregulated inflammation underlies various acute and chronic diseases, requiring therapeutic intervention.

Purpose of the Study:

  • To review novel therapeutic targets for inflammation.
  • To explore alternative approaches for developing anti-inflammatory drugs.
  • To examine endogenous mediators and cellular pathways regulating inflammation and its resolution.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of patents related to inflammatory targets.
  • Focus on endogenous mediators and cellular pathway regulation.

Main Results:

  • Identification of new therapeutic targets.
  • Exploration of alternative drug development strategies.
  • Understanding of mediator-pathway interactions in inflammation.

Conclusions:

  • Novel therapeutic strategies targeting endogenous mediators and cellular pathways are crucial for managing inflammatory diseases.
  • Further research into inflammation resolution mechanisms can yield innovative treatments.
  • Patent landscape analysis highlights key areas for future drug development.

More Related Videos

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

Related Concept Videos

Acute Inflammation I: Inflammatory Response01:26

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation: Introduction01:28

Inflammation: Introduction

Inflammation is a fundamental, protective biological response of vascularized tissues to cellular injury, infection, or harmful stimuli. Its primary function is to eliminate the initial cause of injury, clear necrotic cells and damaged tissue, and initiate the necessary repair processes.Cardinal SignsAcute inflammation presents with classic signs. Redness results from vasodilation and increased blood flow. Heat is due to increased metabolism and circulation. Swelling results from the...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...